Literature DB >> 23459942

Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed IκB kinase activation.

Ken Blackwell1, Laiqun Zhang, Lauren M Workman, Adrian T Ting, Kazuhiro Iwai, Hasem Habelhah.   

Abstract

Tumor necrosis factor alpha (TNF-α)-induced NF-κB activation has been believed to depend on TRAF2- and cIAP1-mediated RIP1 ubiquitination. However, recent findings have challenged the notion that these proteins play essential roles in NF-κB activation. Here, by assessing the kinetics and amplitude of IκB kinase (IKK) activation, we report that TNF-α-induced immediate and robust activation of IKK requires K63-linked and linearly linked ubiquitination of RIP1 and that in the absence of RIP1 expression, TRAF2 and cIAP1 cooperatively induce delayed IKK activation by recruiting LUBAC to TNFR1. Knockdown of HOIP (a component of LUBAC) in RIP1-deficient cells completely impairs the recruitment and activation of IKK but does not affect K63-linked ubiquitination of TRAF2 and recruitment of TAK1 to TNFR1, suggesting that the K63-linked ubiquitin chain is not capable of recruiting IKK in vivo. We also demonstrate that TRAF2 and cIAP1 together, but not either one alone, directly catalyze linearly linked ubiquitination of RIP1. Importantly, in embryonic hepatocytes, TNF-α activates NF-κB through a RIP1-independent pathway. Thus, our findings clarify molecular details of this important signaling mechanism by providing evidence for the existence of two phases of IKK activation: the immediate phase, induced by TRAF2/cIAP1-mediated ubiquitination of RIP1, and the delayed phase, activated by TRAF2/cIAP1-dependent recruitment of LUBAC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23459942      PMCID: PMC3647962          DOI: 10.1128/MCB.01416-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

Authors:  Marc Feldmann; Ravinder N Maini
Journal:  Nat Med       Date:  2003-10       Impact factor: 53.440

2.  Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.

Authors:  Hasem Habelhah; Shoichi Takahashi; Ssang-Goo Cho; Takayuki Kadoya; Toshiki Watanabe; Ze'ev Ronai
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598

3.  Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling.

Authors:  Masahiro Yamamoto; Toru Okamoto; Kiyoshi Takeda; Shintaro Sato; Hideki Sanjo; Satoshi Uematsu; Tatsuya Saitoh; Naoki Yamamoto; Hiroaki Sakurai; Ken J Ishii; Shoji Yamaoka; Taro Kawai; Yoshiharu Matsuura; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2006-07-23       Impact factor: 25.606

Review 4.  Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models.

Authors:  S Gerondakis; R Grumont; R Gugasyan; L Wong; I Isomura; W Ho; A Banerjee
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

5.  RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis.

Authors:  A T Ting; F X Pimentel-Muiños; B Seed
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

6.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.

Authors:  M A Kelliher; S Grimm; Y Ishida; F Kuo; B Z Stanger; P Leder
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

7.  Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

Authors:  M Lewis; L A Tartaglia; A Lee; G L Bennett; G C Rice; G H Wong; E Y Chen; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].

Authors:  Chuan-Jin Wu; Dietrich B Conze; Tao Li; Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Nat Cell Biol       Date:  2006-03-19       Impact factor: 28.824

9.  Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses.

Authors:  Tatsuma Okazaki; Sachiko Sakon; Tomonari Sasazuki; Hiroaki Sakurai; Takahiro Doi; Hideo Yagita; Ko Okumura; Hiroyasu Nakano
Journal:  Biochem Biophys Res Commun       Date:  2003-01-24       Impact factor: 3.575

10.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

Authors:  Chee-Kwee Ea; Li Deng; Zong-Ping Xia; Gabriel Pineda; Zhijian J Chen
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

View more
  23 in total

1.  TRAF2 exerts opposing effects on basal and TNFα-induced activation of the classic IKK complex in hematopoietic cells in mice.

Authors:  Laiqun Zhang; Ken Blackwell; Lauren M Workman; Katherine N Gibson-Corley; Alicia K Olivier; Gail A Bishop; Hasem Habelhah
Journal:  J Cell Sci       Date:  2016-02-12       Impact factor: 5.285

2.  ACTN4 regulates the stability of RIPK1 in melanoma.

Authors:  Yuan Yuan Zhang; Hessam Tabataba; Xiao Ying Liu; Jia Yu Wang; Xu Guang Yan; Margaret Farrelly; Chen Chen Jiang; Su Tang Guo; Tao Liu; Hung-Ying Kao; Rick F Thorne; Xu Dong Zhang; Lei Jin
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

Review 3.  Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling.

Authors:  Axel Witt; Domagoj Vucic
Journal:  Cell Death Differ       Date:  2017-05-05       Impact factor: 15.828

Review 4.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

5.  TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.

Authors:  Laiqun Zhang; Martin R Dittmer; Ken Blackwell; Lauren M Workman; Bruce Hostager; Hasem Habelhah
Journal:  Cell Signal       Date:  2014-11-18       Impact factor: 4.315

6.  RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.

Authors:  Laiqun Zhang; Ken Blackwell; Lauren M Workman; Songhai Chen; Marshall R Pope; Siegfried Janz; Hasem Habelhah
Journal:  Mol Cell Biol       Date:  2015-07-20       Impact factor: 4.272

Review 7.  TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification.

Authors:  Lauren M Workman; Hasem Habelhah
Journal:  Cell Signal       Date:  2013-04-21       Impact factor: 4.315

Review 8.  Sphingolipid metabolites in inflammatory disease.

Authors:  Michael Maceyka; Sarah Spiegel
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

Review 9.  More to Life than NF-κB in TNFR1 Signaling.

Authors:  Adrian T Ting; Mathieu J M Bertrand
Journal:  Trends Immunol       Date:  2016-07-13       Impact factor: 16.687

10.  NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis.

Authors:  L Boutaffala; M J M Bertrand; C Remouchamps; G Seleznik; F Reisinger; M Janas; C Bénézech; M T Fernandes; S Marchetti; F Mair; C Ganeff; A Hupalowska; J-E Ricci; B Becher; J Piette; P Knolle; J Caamano; P Vandenabeele; M Heikenwalder; E Dejardin
Journal:  Cell Death Differ       Date:  2015-06-05       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.